The Radical Insufficiency and Wily Possibilities of RSTEM

Druschke, Caroline Gottschalk

doi:10.13008/2151-2957.1257

Cited by 4 publications

(2 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…As mentioned above, this project was intentionally designed as part of the emerging postcritical, upstream rhetorical research tradition which aims for more direct engagement with the rhetors we study. As noted positively by Caroline Gottschalk Druschke (2017) and critically by Leah Ceccarelli ( 2014), postcritical rhetorical scholarship can look markedly different f rom research that relies more heavily on traditional rhetorical methods. Attenuating rhetorical findings to the epistemic standards of extra-disciplinary audiences often requires re-engaging the insights of our work through quantitative methodologies that carry more value outside of rhetorical boundaries.…”

Section: Methodsmentioning

confidence: 99%

Assessing Perspectivalism in Patient Participation: An Evaluation of FDA Patient and Consumer Representative Programs

Graham

Kessler

Kim

et al. 2018

RHM

View full text Add to dashboard Cite

Recent research in rhetoric of health and medicine (RHM) has worked to evaluate the effectiveness of patient inclusion initiatives in health policy decision-making. Extending this line of research, this article evaluates the extent to which the U.S. Food and Drug Administration's (FDA) patient and consumer representative programs meaningfully engage patient experiences. In so doing, this study provides directed and summative content analyses of pharmaceuticals policy deliberation at 163 FDA drug advisory committee meetings. The results indicate that the current implementation of the patient and consumer representative programs do not adequately ensure that patient experiences are being included as a part of advisory committee deliberation or subsequent pharmaceuticals policy. Additionally, the results presented support the growing concern that attempts to include patient perspectives in health policy may actually further marginalize patient populations.

show abstract

Section: Methodsmentioning

confidence: 99%

Assessing Perspectivalism in Patient Participation: An Evaluation of FDA Patient and Consumer Representative Programs

Graham

Kessler

Kim

et al. 2018

RHM

View full text Add to dashboard Cite

show abstract

“…To this end, I see this book as both a response to and an invitation for discomfort. Rhetorician Caroline Gottschalk Druschke (2017) has argued that rhetorical studies, particularly of science, technology, and medicine, "needs discomfort" to intervene in the spaces and issues that matter most to us (p. 3). "We need-now-to engage with people and things, potentially make fools of ourselves, and labor with others to do the work that most matters to us, our field, and our world" (p. 3).…”

mentioning

confidence: 99%

Stigma Stories: Rhetoric, Lived Experience, and Chronic Illness

Kessler

2022

View full text Add to dashboard Cite

Studying StigmaA Rhetorical Approach to Stories and Lived Experience SIX IN TEN ADULTS in the US live with at least one chronic condition, according to the Centers for Disease Control and Prevention (CDC, 2019a). In other words, over half the US population lives with at least one long-term, likely incurable, condition (CDC, 2021b; National Center for Chronic Disease Pre- vention & Health Promotion, 2012). Such conditions vary widely but include cancer, addiction, diabetes, obesity, Alzheimer's disease, and autoimmune conditions, among many others. Despite research demonstrating an already staggering prevalence of chronic conditions in the US, the number of Americans affected by chronic conditions is only estimated to rise. According to one report, "between 2000 and 2030 the number of Americans with chronic conditions will increase by 37 percent, an increase of 46 million people" (Anderson, 2010, p. 7; see also Wu & Green, 2000). The prevalence of chronic conditions alone is startling; however, concerns don't end there. As a category, chronic conditions disproportionately account for 75 to 90 percent of the overall healthcare costs in the US each year, an estimate that lands somewhere between two and three trillion dollars annually (

show abstract

The Rhetoric of Health and Medicine as a “Teaching Subject”: Lessons from the Medical Humanities and Simulation Pedagogy

Campbell

2017

Technical Communication Quarterly

View full text Add to dashboard Cite

The Rhetoric of Health and Medicine has only begun to intervene in health pedagogy. In contrast, the Medical Humanities has spearheaded curriculum to address dehumanizing trends in medicine. This article argues that rhetorical scholars can align with Medical Humanities' initiatives and also uniquely contribute to health curriculum. Drawing on the author's research on clinical simulation, the article discusses rhetorical methodologies, genre theory, and critical lenses as areas for pedagogical collaboration between rhetoricians and health practitioners.

show abstract

The Radical Insufficiency and Wily Possibilities of RSTEM

Cited by 4 publications

References 12 publications

Assessing Perspectivalism in Patient Participation: An Evaluation of FDA Patient and Consumer Representative Programs

Assessing Perspectivalism in Patient Participation: An Evaluation of FDA Patient and Consumer Representative Programs

Stigma Stories: Rhetoric, Lived Experience, and Chronic Illness

The Rhetoric of Health and Medicine as a “Teaching Subject”: Lessons from the Medical Humanities and Simulation Pedagogy

Contact Info

Product

Resources

About